Kedrion And Kamada Receive FDA Approval Of KEDRAB For Post-Exposure Prophylaxis Against Rabies Infection Post author:Sam Post published:August 24, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Nemaura Medical Develops Rechargeable Transmitter For Sugarbeat July 31, 2017 Mylan Teams Up with Revance Therapeutics to Develop Botox Biosimilar February 28, 2018 Agilent Enhances Exome Sequencing For Clinical Research March 20, 2017